⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors
globenewswire.com
ATHE
VTGN
Bronstein, Gewirtz & Grossman, LLC Encourages Vistagen Therapeutics, Inc. (VTGN) Shareholders to Inquire about Securities Investigation
accessnewswire.com
VTGN
Bronstein, Gewirtz & Grossman, LLC Is Investigating Vistagen Therapeutics, Inc. (VTGN) And Encourages Shareholders to Connect
accessnewswire.com
VTGN
Form 8-K
sec.gov
VTGN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Vistagen Therapeutics, Inc. (VTGN) And Encourages Shareholders to Reach Out
accessnewswire.com
VTGN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Vistagen Therapeutics, Inc. (VTGN) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
VTGN
Lifshitz Law PLLC Announces Investigations of Vistagen Therapeutics, Inc. (NASDAQ: VTGN), CoreWeave, Inc. (NASDAQ: CRWV), Bath and Body Works, Inc. (NYSE: BBWI), and Ardent Health, Inc. (NYSE: ARDT)
accessnewswire.com
VTGN
CRWV
BBWI
ARDT
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Vistagen Therapeutics, Inc. (VTGN) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
VTGN
Vistagen Therapeutics, Inc. (VTGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
VTGN
Form 8-K
sec.gov
VTGN